Showing results (591-600 of 615) with videos related to
Sort By:
Pageof 62
Journal of Neurology|August 14, 2024
Clinical characterization of common pathogenic variants of SOD1-ALS in GermanyMaximilian Wiesenfarth, Yalda Forouhideh-Wiesenfarth, Zeynep Elmas, et al.Annals of Surgery|August 2, 2021
Neoadjuvant Therapy for Resectable Pancreatic Cancer: A New Standard of Care. Pooled Data From 3 Randomized Controlled TrialsDominique L Birrer, Henriette Golcher, Riccardo Casadei, et al.Psychosomatic Medicine|January 14, 2023
Type D Personality as a Risk Factor for Adverse Outcome in Patients With Cardiovascular Disease: An Individual Patient-Data Meta-analysisPaul Lodder, Jelte M Wicherts, Marijn Antens, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 13, 2016
Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening studyAngelica Nordin, Chizuru Akimoto, Anna Wuolikainen, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 14, 2018
Comprehensive analysis of the mutation spectrum in 301 German ALS familiesKathrin Müller, David Brenner, Patrick Weydt, et al.Plos One|May 21, 2014
Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trialVincent Meininger, Pierre-François Pradat, Andrea Corse, et al.European Journal of Neurology|June 11, 2024
Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicenter studyThomas Meyer, Marie Dreger, Torsten Grehl, et al.The Lancet. Neurology|October 18, 2024
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trialJan C Koch, Andreas Leha, Helen Bidner, et al.Journal of Neurology|March 30, 2019
Prognostic factors in ALS: a comparison between Germany and ChinaJohannes Dorst, Lu Chen, Angela Rosenbohm, et al.Annals of Surgery|December 5, 2019
Primary Open Versus Closed Implantation Strategy for Totally Implantable Venous Access Ports: The Multicentre Randomized Controlled PORTAS-3 Trial (DRKS 00004900)Felix J Hüttner, Tom Bruckner, Matthes Hackbusch, et al.Pageof 62